We recently found that combined tumour-directed trafficking and expression of a dominant-negative receptor (DNR) to shield CAR T cells from TGF-β in the immunosuppressive TME synergistically improves CAR T cell efficacy in solid tumours [45]. Here, TGFB1 is linked to neoplasm.